Security Snapshot

NEPHROS INC - Common Stock - $0.001 par value (NEPH) Institutional Ownership

CUSIP: 640671400

13F Institutional Holders and Ownership History from Q3 2019 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

24

Shares (Excl. Options)

2.39MFull value: 2,389,432 · shares · 30 Sep 2026

Price

$3.71

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-2,746,068
Value change
-$9,752,671
Number of holders
24
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
11,026,500
SEC-reported price per share
$3.27
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • NEPH - NEPHROS INC - Common Stock - $0.001 par value is tracked under CUSIP 640671400.
  • 24 institutions reported positions in Q3 2026.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 34 to 24 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $18.99MFull value: $18,993,790 · USD · 30 Jun 2026
    to
    $8.84MFull value: $8,836,943 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 24 institutions filings for Q3 2026.

Open SEC evidence

Security key

640671400

13F reference period

Q3 2026

13F holders

24

13D/G owners

3

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
3
Security
NEPH
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Topline Capital Management, LLC 6.4% +13% $2,618,132 +$409,443 705,696 +19% Topline Capital Management, LLC 30 Sep 2026
DAVIDSON CHARLES E 5.7% $2,807,100 616,945 Charles E. Davidson 14 Sep 2026
WEXFORD CAPITAL LP 2.1% $1,017,102 223,539 Wexford Capital LP 14 Sep 2026
As of 30 Sep 2026, 24 institutional investors reported holding
2.39MFull value: 2,389,432 · shares · 30 Sep 2026
shares of NEPHROS INC - Common Stock - $0.001 par value (NEPH). This represents 22% of the company’s total
11.03MFull value: 11,026,500 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 23 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
21%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Topline Capital Management, LLC 4.9% 535,698 0.44% $1,987,440
MASSACHUSETTS INSTITUTE OF TECHNOLOGY 3.1% 346,813 0.19% $1,286,676
WEXFORD CAPITAL LP 2.1% 231,068 0.11% $829,331
VANGUARD CAPITAL MANAGEMENT LLC 1.8% 198,643 0% $736,966
Johns Hopkins University 1.7% 187,857 0.05% $696,949
Meritage Group LP 1.6% 173,407 0.02% $643,340
Blackstone Inc. 1% 115,605 0% $428,895
RENAISSANCE TECHNOLOGIES LLC 0.64% 71,100 0% $263,781
GEODE CAPITAL MANAGEMENT, LLC 0.64% 70,263 0% $260,756
Mesirow Financial Investment Management, Inc. 0.54% 60,000 0% $222,600
HighTower Advisors, LLC 0.54% 59,710 0% $221,524
ESSEX INVESTMENT MANAGEMENT CO LLC 0.35% 38,927 0.02% $144,419
VANGUARD FIDUCIARY TRUST CO 0.33% 36,901 0% $136,903
BLAIR WILLIAM & CO/IL 0.33% 36,249 0% $134,484
DIMENSIONAL FUND ADVISORS LP 0.2% 22,164 0% $82,228
STATE STREET CORP 0.14% 15,698 0% $58,240
MERCER GLOBAL ADVISORS INC /ADV 0.11% 12,600 0% $46,746
GOLDMAN SACHS GROUP INC 0.11% 11,908 0% $44,179
Jasper Ridge Partners, L.P. 0.1% 11,560 0% $42,888
Cannell & Spears LLC 0.1% 11,000 0% $40,810
ELKHORN PARTNERS LIMITED PARTNERSHIP 0.1% 11,000 0.04% $40,810
BOLTON SECURITIES CORPORATION 0.07% 7,192 0% $26,682
SBI Securities Co., Ltd. 0% 154 0% $571

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
29
Headline period
Q3 2026
Rows shown
1-25 of 29
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 2,389,432 $8,836,943 -$9,752,671 $3.71 24
2026 Q2 5,320,351 $18,993,790 -$195,974 $3.57 34
2026 Q1 5,370,279 $16,003,262 -$119,431 $2.98 27
2025 Q4 5,302,280 $25,875,168 +$1,403,304 $4.88 35
2025 Q3 5,015,032 $23,721,183 +$770,357 $4.73 23
2025 Q2 4,852,312 $19,846,026 +$767,466 $4.09 20
2025 Q1 4,664,676 $8,023,335 -$71,094 $1.72 17
2024 Q4 4,711,852 $6,907,601 +$947 $1.47 17
2024 Q3 4,284,771 $7,333,250 -$66,476 $1.71 17
2024 Q2 4,320,368 $9,159,330 +$116,985 $2.11 18
2024 Q1 4,264,479 $9,398,998 -$169,208 $2.19 18
2023 Q4 4,331,833 $14,986,626 +$148,381 $3.46 18
2023 Q3 4,288,960 $6,347,955 +$12,732 $1.48 14
2023 Q2 4,279,808 $6,634,282 +$34,065 $1.55 15
2023 Q1 4,273,188 $4,574,310 +$8,159 $1.07 17
2022 Q4 4,266,471 $4,940,524 -$78,172 $1.16 18
2022 Q3 4,339,484 $3,949,000 +$17,380 $0.91 17
2022 Q2 632,473 $968,000 -$108,653 $1.53 15
2022 Q1 643,171 $2,827,000 -$4,636,503 $4.39 13
2021 Q4 1,550,944 $9,151,000 -$931,227 $5.90 11
2021 Q3 1,700,497 $14,914,000 +$362,427 $8.77 13
2021 Q2 5,916,801 $60,109,000 +$672,777 $10.15 15
2021 Q1 5,231,367 $34,791,000 -$660,885 $6.65 17
2020 Q4 5,282,295 $45,322,000 +$2,352,286 $8.58 14
2020 Q3 4,474,719 $32,353,000 -$269,921 $7.23 15
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .